Cattle

OCTAVAC Atlas

COMPOSITION
Anatoxine Cl. Perfringens type A*………………...........…………………………………………> 2 UI
Anatoxine Cl. Perfringens type B*………………………………........…………………………. > 10 UI
Anatoxine Cl. Perfringens type C*……………………………….................…………………. > 10 UI
Anatoxine Cl. Perfringens type D*………………………………….………..................……. > 5 UI
Anatoxine Cl. septicum* ………………………………………………...................………………> 2,5UI
Anatoxine Cl. novyi * type B ……………………………………….................………………...> 3.5 UI
Anatoxine Cl. sordelli * ……………………………………………….................………………….> 5 UI
Anaculture and toxoid of Clostridium chauvoei***QSP to induce an immune response expressed in IU of antitoxin.** QSP to induce total protection of guinea pigs
Excipient qs ……… .. ………………………………………………………… .................... ……… ..… 2 ml
PHARMACEUTICAL PROPERTIES
The vaccine contains immunogenic toxins from Clostridium perfringens types A, B, C and D, Clostridium septicum, Clostridium novyi type B and Clostridium sordelli with anaculture and toxoid Clostridium chauvoei, which are the most common etiological agents of toxi-infections clostridians of ruminants (enterotoxemia, gas gangrene, symptomatic anthrax). These toxoids and anaculture, injected in sufficient quantities, are capable of inducing immunity in vaccinated animals. The vaccine is recommended for the prevention of enterotoxemia, gas gangrene and symptomatic anthrax in endemic regions.
TARGET SPECIES
Sheep, goats and cattle.
INDICATIONS
Prevention of Enterotoxemia, gas gangrene and symptomatic anthrax of ruminants by active immunization.
PHARMACEUTICAL PROPERTIES
The vaccine contains immunogenic toxins from Clostridium perfringens types A, B, C and D, Clostridium septicum, Clostridium novyi type B and Clostridium sordelli with anaculture and toxoid Clostridium chauvoei, which are the most common etiological agents of toxi-infections clostridians of ruminants (enterotoxemia, gas gangrene, symptomatic anthrax). These toxoids and anaculture, injected in sufficient quantities, are capable of inducing immunity in vaccinated animals. The vaccine is recommended for the prevention of enterotoxemia, gas gangrene and symptomatic anthrax in endemic regions.
TARGET SPECIES
Sheep, goats and cattle.
INDICATIONS
Prevention of Enterotoxemia, gas gangrene and symptomatic anthrax of ruminants by active immunization.
ADMINISTRATION AND DOSAGE
OCTAVAC Atlas is intended to be administered by the route:
Subcutaneous: in front of or behind the shoulder for cattle, and behind the elbow or on the inside of the thigh for sheep and goats.
At the dose of:

Cattle: 4 ml
Sheep: 2 ml
Goats: 2 ml

CONTRAINDICATIONS AND INTERACTIONS
Avoid vaccinating pregnant goats.
SIDE EFFECTS
A local edematous reaction may be observed. Always be wary, in a highly contaminated environment, of the locations of general infections in apparently healthy carriers of germs; preferably operate on animals on an empty stomach, carefully disinfect the site of inoculation and avoid any untimely trauma. Very rarely anaphylactic shock is observed in sensitized animals.
PRECAUTIONS FOR USE
- Vigorously shake the vaccine before use in order to resuspend the precipitate consisting of alumina hydroxide.
- Respect the usual aseptic conditions
- Vaccinate only animals in good health
- Avoid injecting the vaccine at too low a temperature
- Avoid vaccinating during very hot weather
- Respect the dosage.
- Keep the product away from light and at a temperature between 2 ° C and 8 ° C.
- The vaccine should not be frozen.
- Any opened bottle must be entirely used or discarded.
WITHDRAWAL PERIOD
No waiting period is necessary.
STORAGE CONDITIONS
keep the product in the original packaging,
protect from light and at a temperature ≤ 25 ° C.
PHARMACEUTICAL FORM AND PRESENTATION